LOX and neoplasm: Western blot analysis confirmed higher levels of LOX expression in the MDA-MB-231 tumor microenvironment compared to those of the MDA-MB-231 tumors treated with the LOX inhibitor or the MCF-7 tumors (Figure 6b).